Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentostatin, Cyclophosphamide, and Rituximab With or Without Avastin for Previously Untreated B-CLL
NCT00816595Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2009
- Primary completion
- Jul 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by Mayo Clinic. Started Feb 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT00816595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00816595.